(Q71816383)

English

Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis

scientific article published on 01 November 1995

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589632%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589632%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

1 reference

based on heuristic

inferred from title

author name string

P. Kiilholma

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589632

28 May 2024

R. Tuimala

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589632

28 May 2024

S. Kivinen

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589632

28 May 2024

M. Korhonen

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589632

28 May 2024

E. Hagman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589632

28 May 2024

language of work or name

0 references

publication date

1 November 1995

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589632%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

full work available at URL

https://doi.org/10.1016/s0015-0282(16)57900-x

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A7589632

28 May 2024

https://api.elsevier.com/content/article/PII:S001502821657900X?httpAccept=text/xml

1 reference

10.1016/S0015-0282(16)57900-X

https://api.crossref.org/works/10.1016/S0015-0282(16)57900-X

28 May 2024

https://api.elsevier.com/content/article/PII:S001502821657900X?httpAccept=text/plain

1 reference

10.1016/S0015-0282(16)57900-X

https://api.crossref.org/works/10.1016/S0015-0282(16)57900-X

28 May 2024

Fertility and Sterility

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589632%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

64

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589632%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589632%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

903-908

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589632%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

A comparison of nafarelin acetate and danazol in the treatment of endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

Hormone treatment of endometriosis: the estrogen threshold hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

Revised American Fertility Society classification of endometriosis: 1985

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

Gonadotropin-releasing hormone agonists: strategies for managing the hypoestrogenic effects of therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

Can hormone replacement therapy be used during medical therapy of endometriosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

Treatment of endometriosis with goserelin depot, a long-acting gonadotropin-releasing hormone agonist analog: endocrine and clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

Gonadotropin-releasing hormone agonists: treatment of endometriosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

Severe endometriosis treated with gonadotrophin releasing hormone agonist and continuous combined hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2957900-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0015-0282(16)57900-X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589632%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7589632%20AND%20SRC:MED&resulttype=core&format=json

21 October 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q71816383&oldid=2166703319"